# Carlsmed to Participate in Upcoming Investor Conferences

- Published: 2026-11-16
- Author: [Healthcare News](https://healthcarenews.io/author/healthcarenews-io.md)
- Topics: [News](https://healthcarenews.io/news.md)
- Source: https://healthcarenews.io/news/carlsmed-to-participate-in-upcoming-investor-conferences/
- Publication: Healthcare News
- Publisher: Connectively (Terkel, Inc.)
- Editorial policy: https://healthcarenews.io/editorial-policy/

CARLSBAD, Calif., Nov. 16, 2026 [(GLOBE NEWSWIRE)](https://www.globenewswire.com) -- <a href="https://www.globenewswire.com/Tracker?data=NEWTvVJABmmlXXebQ88OxHOqw-_R1MdLgCuS28SXiOlF-91W1j2fXWpV26d_IX4rOLD-OxgpmAopAavXFRFJcw==" rel="nofollow">Carlsmed, Inc.</a> (Nasdaq: CARL) (“Carlsmed” or the “Company”), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced that management will participate in the following investor conferences:

<table><tbody><tr><td>&nbsp;</td><td><strong>Ninth Annual Evercore Healthcare Conference</strong></td></tr><tr><td>&nbsp;</td><td>Format: Fireside chat</td></tr><tr><td>&nbsp;</td><td>Date: Monday, November 30, 2026</td></tr><tr><td>&nbsp;</td><td>Time: 12:55 p.m. Eastern time (9:55 a.m. Pacific time)</td></tr><tr><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>&nbsp;</td><td><strong>Piper Sandler 38</strong><sup><strong>th</strong></sup><strong> Annual Healthcare Conference</strong></td></tr><tr><td>&nbsp;</td><td>Format: Fireside chat</td></tr><tr><td>&nbsp;</td><td>Date: Wednesday, December 2, 2026&nbsp;</td></tr><tr><td>&nbsp;</td><td>Time: 2:30 p.m. Eastern time (11:30 a.m. Pacific time)</td></tr><tr><td>&nbsp;</td><td>&nbsp;</td></tr></tbody></table>

Live and archived webcasts for these events will be available in the Events & Presentations section of the company’s investor website at <a href="https://www.globenewswire.com/Tracker?data=t2G5snsCUX2P-UDrE8d0Ftw1g_vD49htEApxByKCaQOWGuLaYdcp6mpNyNDkRJE8HseA1nSpdj_NvYDAjyoN521DMwsLCSLmjsBubVlDfcM=" rel="nofollow">investors.carlsmed.com</a>.

**About Carlsmed**

Carlsmed is a medical technology company pioneering AI-enabled personalized spine surgery solutions with a mission to improve outcomes and decrease the cost of healthcare for spine surgery and beyond.

**Investor Relations**  
<a href="https://www.globenewswire.com/Tracker?data=9edlpbhJaEpCjMXs0Ub0oJXVNOemsvkmV_znxl7Jt4JG3EOA-CFJiIbunXfywodWgDUZpPUFa6M1z1pk8K_RhQ==" rel="nofollow">IR@Carlsmed.com</a>

**Media**  
<a href="https://www.globenewswire.com/Tracker?data=-BJ-lLxt89bWT6QmAfJj_OntjHZbzC-SfYHy-JE-aT7LqA_Tn1NCj383E2u-7BsXmLPDxxuk5SNvdebNjPDQ-Tlcl-E7U9pYqRGaRVQ6eUA=" rel="nofollow">Marketing@Carlsmed.com</a>  
  

  
![](https://ml.globenewswire.com/media/ZTdlYjJjMDctYmFhNS00ZmI0LThkNjItMjJkM2ViNzA4NDkzLTEyMDUyMTctMjAyNi0xMS0xNi1lbg==/tiny/Carlsmed.png)

## Related

- [Windward Bio Announces Closing of $251.2 Million Initial Public Offering and Concurrent Private Placement, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares](https://healthcarenews.io/news/windward-bio-announces-closing-of-251-2-million-initial-public-offering-and-concurrent-pri.md)
- [Stipple Bio Announces Multi-Target Multi-Modality Oncology Research Collaboration with Lilly](https://healthcarenews.io/news/stipple-bio-announces-multi-target-multi-modality-oncology-research-collaboration-with-lil.md)
- [20/20 BioLabs Reports Third Quarter 2026 Financial Results and Recent Business Updates](https://healthcarenews.io/news/20-20-biolabs-reports-third-quarter-2026-financial-results-and-recent-business-updates.md)
- [Rosemont Pharmaceuticals to acquire Aytu BioPharma to accelerate US expansion](https://healthcarenews.io/news/rosemont-pharmaceuticals-to-acquire-aytu-biopharma-to-accelerate-us-expansion.md)
